Gland Pharma Limited IPO Message Board (Page 24)

I got a call from my broker regarding purchase of HPCL shares, should I buy it. Please advice

85/88

Latest GMP please

Friends only one thing its Chinese connection company, government any decisions washed away all your hard money, so avoid

@Aniketiaf ji, there is some calculation mistake in ntpc buyback process. Suppose you have 1600 shares & acceptance ratio is say 40 % so 640 shares confirm buy back by company but if final acceptance ratio goes up to 50 % than 800 shares will be taken back only if you tender full 1600 shares. As per your strategy if you sell 50% shares immediately after record date (assuming 50 % final acceptance ratio) than your 800 shares will not be taken back as you will only tender 800 shares instead of 1600. They will take back 640 (40%) confirm shares plus 10 % of 160 shares that is 16 more, so total 816 shares will be taken back if you submit 800 shares on buyback. Sharing details with my personal experience on QUICK HEAL BUYBACK. Hope its clear

Yes sir ji, you are right.

Actually whenever I purchased share for tender in buyback , I kept all till buyback starts and tendered all. Many times my all shares had been taken ( IOC, nmdc, ongc, TCS.......)
Hence not experienced such condition.
So,
Now in NTPC , one can sell 50% of share after record date whenever rate favours and after finalization of Entitlement Ratio(ER) he can re-purchase same qty if rate favours and tender all during buyback.

Thanks.

Can one participate in buy back without giving POA to broker? I have trading account with upstox and I have not given POA. Two years ago I tried but at that time I got message that I can not participate in buy back without giving POA.

Must apply.. I know people will shout but it's truth high growth companies always gives listing gain..it doesn't matter whether higher price band or China factor..one must see only profitability..of don't trust then check FII AND NII data on last day..it's better to arrage funds and forms from today rather to run on last day.. please kept this message till last day of ipo..

Gland pharma Q1 result for FY 2020-21 is also showing growth. Let's have a look on PAT and EPS of the company.

year -> Q1-FY2021-- --FY 2020-- FY 2019-- FY 2018
----------------------
PAT --> 313 Cr(3 months)--773 Cr ------ 452 Cr ----- 321 Cr
EPS --> 20.24 (3 months)-- 49.88------------29.16--------20.72


PAT and EPS are only for 3 months current year. If we assume the same growth for 12 months, then PAT and EPS for FY2020-21 will be 1252 Cr and 80.96

Very large issue size and Chinese promoters are two reasons not to apply in this IPO.


Waiting for anchor placement list and QIB interest on final day of subscription. Then I will decide to apply or not.

Avoid this IPO and buy bpcl at current market price. Target 450 within 3 months with 300 stop loss.
I have bought 200 shares today at market price.
Please deep think on it.

Gmp (100) ..

Pradip IPO,

Company has very strong balance sheet.
But,
The size of issue (about 6500 Cr) is a very big concern for me.
It may give max 6/7 % listing gain,
But again downside will have no limits.

I will not apply.

In stead,
I am concentrating on NTPC buy back for a profit of 15-35% within 2 months.

Thanks.

Aniket Sir,
Yes. I have purchased NTPC qty 1800 in same PAN. I will sell tomorrow morning qty 75.
Thank you for valuable guidance.????????

Today I also purchased 1725 Ntpc each at 86 in two of my Demet account for participate in buyback.
How many you have purchased sir.

Should we invest on this IPO or not is any other IPO is coming in November

FV has no value in pe ratio or any other analysis,that being said good company for long term.
I will apply and wait for it to come towards 1300 to add more.

Chinese Fosun Pharma acquired 74% stake in Gland pharma 3 years back @605 per share and now they want 1500 per share although companies EPS also increased from 20 to 50 in last 3 years but price is so high and due to Chinese promoter it is a major concern for the future outlook of this company. it may be very difficult for this company due to ant china sentiment and may be some regulatory issue or something else.....
Fosun Pharma spent 7K crores 3 years back and will taken back now 3K crores with 58% stake in gland pharma after the issue....

company is good, balance sheet is very good, fundamental and growth is also good but high price and chinese promoter is a big concern....

दिमाग तो सोच रहा है.....पर दिल मना कर रहा है....
so i am not applying.....

Patel Sir

Same here "दिमाग तो सोच रहा है.....पर दिल मना कर रहा है...."

BTW Not decide yet

Buy HPCL in open market with SL of 210 and sell at 239, irrespective of buy-back offer process. It is in strong momentum and better future quarterly results expected.

Pl elaborate process of ntpc buyback process. Whethet company will send any form for that means how one will take part in buyback process

primum 65/70

Only seller in this counter .but not traded

It will be great if someone updates price, EPS comparison of Gland Pharma with listed peers

Coming back to gland pharma , price band is disappointing, it may not sail through...

@Amit ji, with all due respect, we've enough QIB (please read LIC!) & retailers who will make this issue sail through :). The recent example is UTI!

@techuser
Why would LIC try to help a chinese promoter?

Avoid extremely, otherwise in future all the companies will do like Gland.